Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Safety and Utility of Extra-Cardiac Vagal Stimulation in the Study and Ablation of Supraventricular Tachycardia
  • +6
  • Jose Pachon-M,
  • Enrique Indalecio Pachon,
  • Tasso J. Lobo,
  • Tomás Pena,
  • Carlos Pachón,
  • Juan Pachon,
  • Christian Higuti,
  • Maria Pachon,
  • John Clark
Jose Pachon-M
Universidade Federal de Sao Paulo - Campus Sao Paulo

Corresponding Author:[email protected]

Author Profile
Enrique Indalecio Pachon
Universidade Federal de Sao Paulo - Campus Sao Paulo
Author Profile
Tasso J. Lobo
Hospital do Coracao
Author Profile
Tomás Pena
Hospital do Coracao
Author Profile
Carlos Pachón
Hospital do Coracao
Author Profile
Juan Pachon
Universidade Federal de Sao Paulo - Campus Sao Paulo
Author Profile
Christian Higuti
Hospital do Coracao
Author Profile
Maria Pachon
Hospital do Coracao
Author Profile
John Clark
Akron Children's Hospital
Author Profile

Abstract

Background: The differential diagnosis of supraventricular tachycardias(SVTs) is essential during radiofrequency(RF) ablation. The Extracardiac Vagal Stimulation(ECVS), introduced in 2015, offers new insights for electrophysiologic studies and ablation by allowing a controlled vagal effect on the heart. Methods: A prospective study of 625 patients with SVT ablation indication. ECVS was performed using a regular electrophysiology catheter to study atrioventricular(AV) and ventriculo-atrial(VA) conduction and their effects on tachycardia. Baseline ECVS was performed to determine the optimal position for right or left ECVS, near the jugular foramen. ECVS was repeated during atrial and ventricular pacing(VP) to monitor the procedure’s progression and ensure successful endpoints. Results: ECVS was successful in 611/625 patients(98%), 381(62.3%) had AV node reentry tachycardia(AVNRT), and 230(37.6%) Accessory Pathway(AP), including 135(58.7%) manifest AP(WPW) and 95(41.3%) concealed AP. ECVS+VP in 33 patients with atypical AVNRT yielded VA block in 32(97%), suggesting VA conduction solely via the AV node. In contrast, 57 patients with concealed para-septal AP maintained VA conduction during ECVS, confirming AP. ECVS proved to be a fast, reliable, and practical additional EP tool: VA block indicated AVNRT, while persitent VA conduction suggested AP. Additionally, ECVS was highly effective in revealing and confirming successful AP ablation by demonstrating absence of AV and VA anomalous conduction. Conclusion: ECVS was a valuable tool in the diagnosis and ablation of SVTs. It allowed reproducible AV and VA block through normal pathways, easily identifying AVNRT and concealed, intermittent, or subtle AP. It was particularly useful in complex cases involving concealed AP and atypical AVNRT tachycardia.